Evonik Industries Warns of Q3 Slowdown, Cuts Forecasts
Evonik Industries has announced a significant slowdown in its third quarter of 2025, with an adjusted EBITDA expected to be around 420 to 460 million euros. This is a substantial drop from the previous quarter's 509 million euros and has led to a decline in the company's stock.
The German chemical company attributed this weakness to persistently low demand across all business areas and nearly all end markets. Customers have shown restraint, impacting Evonik's overall performance. As a result, the company has revised its full-year forecast for adjusted EBITDA down to approximately 1.9 billion euros from the previous year's 2.065 billion euros. Revenue is also expected to be significantly lower, at around 3.4 billion euros compared to last year's 3.8 billion euros.
Evonik's stock has reacted negatively to these preliminary results, falling below the stop-loss level of 16.00 euros and being stopped out.
Evonik Industries' third quarter is shaping up to be significantly weaker than the previous quarter, with adjusted EBITDA and revenue both expected to decrease. The company's stock has also been impacted, with investors reacting to the published preliminary results. Evonik continues to monitor the market and adjust its forecasts accordingly.
Read also:
- Crooked House Pub's Demolition: Council Orders Rebuild, Debate on Historic Building Protections
- Shaping India's Economic Progression: Readying the Financial System for Tomorrow
- Conflict between Ben & Jerry's co-founder and Unilever over Gaza issues leads to resignation of co-founder
- Two farmers in Zambia take legal action against two firms with Chinese connections, alleging an ecological disaster caused by their operations.
